A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern Medicine meta-analysis published in JAMA Oncology.
Browsing: Clinical Breakthroughs
More than 60 percent of physicians and medical students reporting delaying having children and building a family due to medical training, with half also having regretted doing so, according to recent survey findings published in JAMA Internal Medicine.
Northwestern University investigators have developed the first electronic device for continuously monitoring the health of transplanted organs in real time.
Electronic health record-based messages delivered solely to clinicians increased referral to tobacco use treatment for cancer patients who smoke, according to a recent study published in the Journal of Clinical Oncology.
Sexual minority women have a higher risk of postpartum depression but are less likely to have their sexual identities documented in electronic medical records, according to a Northwestern Medicine study published in JAMA Psychiatry.
Combining immunotherapy with a tumor-targeted virus may help extend survival in some patients with recurrent glioblastoma, according to the results of a trial published in Nature Medicine.
Northwestern Medicine scientists have developed a new cellular model of uterine fibroids that stem from a common genetic mutation, which will accelerate further research and treatment development, according to findings published in Nature Communications.
A new drug used to treat cancer may also prevent allergic reactions to peanuts, according to a study published in the Journal of Clinical Investigation.
Time-restricted eating without calorie counting was as effective as a calorie restriction diet for weight loss and cardiometabolic risk reduction in obese adults, according to findings published in Annals of Internal Medicine.
Testing performance of rapid antigen tests for SARS-CoV-2 improved for both asymptomatic and symptomatic patients after testing multiple times in 48-hour intervals, according to findings published in the Annals of Internal Medicine.